Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

The Pet Vet acquires The Vet
“I have always been of the opinion that if you take care of your colleagues, they will take care of your customers" - Dr Mel Fuller, The Pet Vet.

The independent group has purchased eight surgeries from CVS.

Family-owned independent practice The Pet Vet has announced the acquisition of eight surgeries from CVS Group plc.

The purchase of all eight The Vet-branded surgeries comes after CVS agreed to sell off its £20.4m acquisition of Quality Pet Care. Earlier this year, an investigation by the UK Competition and Markets Authority (CMA) concluded that the CVS takeover would reduce competition in Bristol, Nottingham, Portsmouth, Southampton and Warrington. 

The CMA warned that it would investigate further unless CVS could provide satisfactory solutions to address its concerns. In its response, CVS offered to divest the entire The Vet business, to which the CMS agreed (27 June).

The Pet Vet was founded in 2011 by University of Bristol graduate Dr Rob Jones.
Now with 12 practices to its name, the group claims to be the largest independent family owned practice in the UK and the only one with “a national presence”.

In a press release, The Pet Vet said it had secured £3.1m in funding earlier this year and that it was able to snap up The Vet when it went onto the market in April 2022. 

Dr Mel Fuller, MD of The Pet Vet, said: "The Pet Vet is absolutely delighted to welcome all The Vet colleagues into our family. Our commitment is to continual reinvestment of profits in the development of our teams, our services and in new technology, making our surgeries fulfilling places to work and offering high-quality first opinion veterinary services.
 
“I have always been of the opinion that if you take care of your colleagues, they will take care of your customers. Our commitment to reinvesting profits has also allowed us to develop centres of excellence for orthopaedic and soft tissue surgery, imaging and dentistry, removing the need for external referral and enabling us to offer our services to other practices within our regions. 
 
She continued: "The acquisition of The Vet gives us scope to further expand our expertise and services, offer even greater career progression, enhance our buying power and increase our influence on the overall quality of first opinion veterinary care in the UK.”

The Pet Vet chairman Rob Jones added: "With nearly 70 per cent of the veterinary practice market by revenue already in the ownership of major corporations, a fact of which most consumers are still completely unaware, this is a real opportunity for us as a family business to make a positive difference for pet owners.
 
"Our acquisition of The Vet will allow us to further advance in-house provision, giving our vets more variety and stimulation in their working day and even greater opportunities for professional development."

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.